ISSN: 2161-1025
Grim reaping the benefits of the BCL-2 selective antagonist, Venetoclax, Venclexta™ for the treatment of hematological malignancies
Deepak Sampath
Improvements of colorectal cancer screening by development and implementation blood-based biomarker concepts
Hans J Nielsen
Abzymes as highly informative and unique biomarkers of the newest generation to monitor chronic autoimmune disorders at subclinical and clinical stages to predict features of the course
Sergey Suchkov
Evaluation of early changes of cartilage biomarkers following arthroscopic meniscectomy in young Egyptian adults
Moustafa Rizk
https://sekillinickyazma.com.tr/
